Last updated: 2026-09-06 16:46:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Journey Medical Corporation (DERM) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $7.87, with a market capitalization of $219.30M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.31 to $9.56. This page covers its latest market performance, valuation, price trends and company information.
$219.30M | |
$8.02 | |
$38.75 | |
$1.02 | |
$7.90 | |
48.99K | |
-- | |
-- | |
$9.56 | |
$4.31 | |
-- | |
-- |
Journey Medical Corporation (DERM) last closed at $7.90 as of 2026-09-04 23:31:00, unchanged from the previous close of $7.90.
During the latest regular trading session, DERM traded between $1.02 and $38.75, with a volume of 48.99K shares. The closing price was near the lower end and near the upper end of its 52-week range.
Over the past seven days, Journey Medical Corporation (DERM) moved from $7.49 to $7.87, representing a gain of 5.06% ($0.38).
The stock traded between $7.80 and $8.08 during the period. The latest price is near the lower end of the 7-day range, indicating strong upward.
The average daily volume was 90.99 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 67.9%
DERM is currently trading at $7.87, placing it 67.9% of the way from its 52-week low of $4.31 to its 52-week high of $9.56. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 58 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Journey Medical Corporation (DERM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.